National Asset Management, Inc. Iterum Therapeutics PLC Transaction History

National Asset Management, Inc.

  • $3.82 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$0.54 - $2.29 $17,334 - $73,509
-32,100 Closed
0 $0
Q2 2021

Aug 10, 2021
SELL
$0.97 - $2.39 $48,694 - $119,978
-50,200 Reduced 61.0%
32,100 $75,000
Q1 2021

May 13, 2021
BUY
$0.97 - $2.73 $79,831 - $224,679
82,300 New
82,300 $117,000

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $13.2M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email